PTGER4 and hepatocellular carcinoma: Therefore, the anti-PTGER4 inhibitor AAT-008 efficiently attenuates HCC development in a mouse model by restoring the anti-cancer immunosurveillance function of DCs and cytotoxic T cells [132].